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Abstract
Alpha-fetoprotein (AFP)-producing lung adenocarcinoma is a rare type of lung cancer, with its characteristics not
yet fully clarified. We recently encountered a case of this type of lung cancer. The patient was a 69-year-old man
who consulted an internist with the chief complaint of epigastric pain. Chest X-ray and CT revealed a lobulated
mass measuring 70 mm in diameter in the right lower lung field and a metastasis in the right hilar lymph nodes.
Of the tumor markers, the serum AFP was elevated (4620 ng/ml), and the serum carcinoembryonic antigen and
carbohydrate antigen 19-9 were also slightly elevated. Transbronchial lung biopsy revealed the diagnosis of lung
cancer. Under thoracoscopic assistance, right lower lobectomy + mediastinal lymph node dissection was carried
out. Immunostaining showed the tumor cells to be AFP-positive. The tumor was thus diagnosed as an AFP-
producing lung adenocarcinoma. The patient followed an uneventful clinical course after the surgery, with serum
AFP decreasing to the normal range by about 2 weeks after the surgery. As of this writing, no sign of tumor
recurrence has been noted. This case is presented here with a review of the literature.
Background
Aalpha-fetoprotein (AFP) is a type of protein formed in
the fetal liver and yolk sac and is detected in the fetal
serum. In regard to the pathological significance of this
p r o t e i ni na d u l t s ,s e r u mA F Pi so f t e ne l e v a t e di n
patients with liver cancer or gonadal germ cell tumors,
such as yolk sac tumor. Because the serum AFP level
decreases in response to effective treatment, measure-
ment of the serum AFP level is carried out during fol-
low-up of patients after treatment or for the detection
of tumor recurrence. AFP-producing ovarian cancer and
gastric cancer have also been reported, whereas AFP-
producing liver cancer is rare. Because AFP-producing
lung cancer has scarcely been reported, the clinical fea-
tures of this type of lung cancer are still unclear. In this
context, we report a case of this type of cancer that we
encountered recently.
Case presentation
A 69-year-old man consulted a nearby internal medicine
clinic with the chief complaint of epigastric pain. He
was diagnosed as having gastroesophageal reflux and
i n i t i a t e do nt r e a t m e n t .Ac h e s tx - r a yp e r f o r m e da tt h a t
time revealed a mass in the right lower lung field. The
patient had a history of smoking (Brinkman index:
1800) and had been diagnosed earlier as having pulmon-
ary emphysema. He had the past of the alcoholic hepati-
tis. His family history was not noteworthy. He was 160
cm tall and weighed 55 kg. Physical examination
revealed no abnormalities. A chest x-ray revealed a mass
measuring 65 mm in diameter in the right lower lung
field (Figure 1). Chest CT revealed a lobulated mass
measuring 65 mm in diameter involving S9 and S10 of
the right lung, as well as an enlarged right hilar lymph
node (Figure 2). Abdominal CT revealed no lesions in
the liver, gallbladder, or pancreas. FDG-PET revealed
uptake in the mass (SUV: 8.1) in the right lung and in
the swelling of #10 lymph node (SUV: 4.1). No abnor-
mal FDG accumulation was noted in any other organ.
Serum biochemical tests did not reveal any evidence of
hepatic dysfunction or hepatitis B or C. Of the tumor
markers, serum carbohydrate1 2 - 5( C A 1 2 - 5 ) ,n e u r o n -
specific enolase (NSE), Sialyl Lewis X (SLX), b-human
chorionic gonadotropin (bHCG), pro-gastrin releasing
peptide (PRO-GRF), and cytokeratin 19 fragment
(CYFRA) levels were within normal range, while the
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serum carcinoembryonic antigen (CEA; 6.6 ng/ml) and
carbohydrate antigen 19-9 (CA19-9; 46.6 ng/ml) were
slightly elevated. Transbronchial lung biopsy led to the
diagnosis of AFP-producing lung carcinoma. Surgical
treatment was selected on the basis of the preoperative
tumor stage (T2N0M0). Right lower lobectomy + med-
iastinal lymph node dissection excision was carried out
by video assisted thoracic surgery. The resected tumor
measured 6.5 cm in diameter and was a solid tumor
(Figure 3). Histopathologically, the tumor was composed
of tumor cells with relatively irregular nuclear sizes and
cylindrical, partially eosinophilic and dimly bright cell
bodies showing little polymorphism, leading to the diag-
nosis of moderately differentiated adenocarcinoma (p0,
pm0, ly1, v0). Lymph node metastasis was noted in #7,
#10 and #11i lymph nodes, which led to a revision of
t h et u m o rs t a g et oT 2 b N 2 M 0 / s t a g e ⅢA. Immnohisto-
chemical staining for AFP revealed positive staining of a
number of tumor cells for AFP, leading to the diagnosis
of AFP-producing lung adenocarcinoma (Figure 4, 5).
The cells also showed positive staining for cytokeratine
(CK)18, CK19, and anti-hepatocyte antibody. Thus,
although the histological and morphological features of
the tumor differed from those of hepatocellular carci-
noma, the chromatic responses of the tumor to immu-
nostaining were close to those known for hepatocytes.
Of the indicators of the tumor malignancy grade, tumor
protein 53 was negative, and the MIB-1 index was
slightly high (40%). The postoperative course was favor-
able, and the serum AFP level returned to normal range
by about 2 weeks after the surgery. At present, the
Figure 2 Chest CT revealed a lobulated mass measuring 65
mm in diameter involving S9 and S10 of the right lung
Figure 1 A chest x-ray revealed a mass measuring 65 mm in
diameter in the right lower lung field.
Figure 3 A macroscopic specimen showed that the resected
tumor measured 6.5 cm in diameter and was a solid tumor
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Uracil), and has not, until date, shown any signs of
tumor recurrence.
Conclusions
AFP is one of the fetal proteins with a molecular weight
that is intermediate between that of albumin and a1-
globulin. It is produced by the fetal liver, yolk sac, and
gastrointestinal cells. In relation to its pathological sig-
nificance, serum AFP is useful as a tumor marker in
patients with liver cancer. In adults showing elevated
serum AFP levels, the malignant diseases requiring dif-
ferential diagnosis include liver cancer, germ cell tumors
(e.g., yolk sac tumor), and metastatic lung cancer, and
the benign diseases requiring differential diagnosis
include acute or chronic hepatitis, liver cirrhosis, and
congenital biliary atresia [1-3]. It has been reported that
AFP-producing tumors account for about 2%-8% of all
cases of gastric cancer, and that the percentage is higher
among cases of advanced gastric cancer [4,5]. Only a
small number of reports have been published of cases
with AFP-producing lung cancer; therefore, the patho-
physiology and clinical characteristics of AFP-producing
lung cancer have not yet been adequately clarified.
AFP-producing lung cancer was first reported by Cor-
lin et al. [6] and has since been reported to account for
about 2% of all lung cancers [7]. Histologically, adeno-
carcinoma (often poorly differentiated adenocarcinoma)
accounts for the most of AFP-producing lung cancers.
Furthermore, large-cell carcinoma accounts for 25% of
all AFP-producing lung cancers. Thus, adenocarcinoma
and large-cell carcinoma account for nearly all cases of
AFP-producing lung cancer [8], although rare cases of
AFP-producing squamous cell carcinoma [9] and AFP-
producing carcinoid [10] have also been reported. As
stated above, AFP-producing gastric cancer shows a
high propensity for metastasizing to the liver and lymph
nodes, and its prognosis is reported to be poorer as
compared with that of non-AFP-producing gastric can-
cer. In relation to AFP-producing lung cancer, it must
be kept in mind during the follow-up of these patients
that the percentage of cases with poorly differentiated
adenocarcinoma and the frequency of a high MIB-1
index are significantly higher in these cases than in
those with non-AFP-producing liver cancer [11] during
the follow-up of patients.
In regard to tumor markers, cases of AFP-producing
liver cancer presenting with elevated serum CEA or
HCG levels have been reported [12]. In the present case
also, slight elevation of the serum CEA and CA19-9
levels was noted in addition to elevation of the serum
AFP. The serum levels of these tumor markers returned
to normal soon after tumor resection, and their patholo-
gical significance remained unknown.
The concept “hepatoid carcinoma” has been proposed
in connection with this disease [13,14]. This concept is
used to indicate adenocarcinoma composed of a mixture
of hepatoid components (cancer assuming the form of a
hepatocellular carcinoma) and papillary components.
Cases of hepatoid carcinoma affecting the pancreas, kid-
ney, duodenum, gallbladder, etc. have been reported.
Immunohistochemically, AFP is found in both the hepa-
toid component and the papillary component of hepa-
toid carcinomas. If the hepatoid component is
dominant, the term “hepatoid-adenocarcinoma” is used.
When the tumor keratin expression profile was analyzed
in the present case, a very small percentage of the cells
were found to be positive for CK7, whereas CK20 and
TIF-1 were negative, the profile thus differing slightly
from the profile known for typical lung cancer.
Figure 4 Histological findings of tumor showed pulmonary
adenocarcinoma (HE × 100)
Figure 5 Immnohistochemical findings showed that positive
staining of a number of tumor cells for AFP, leading to the
diagnosis of AFP-producing lung adenocarcinoma. (×100)
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hepatocellular carcinoma in terms of the histological
and morphological features, which eventually led to the
final diagnosis of AFP-producing lung adenocarcinoma.
The number of cases with this type of tumor reported
until date is rather small. Further accumulation of cases
and analysis of data on the malignancy grade and long-
term prognosis of AFP-producing lung adenocarcinoma
would be desirable.
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